26,548.45
(-49.04)
(-0.18%)
05 Aug , 2026 | 02:54 PM
Open
26,657.3
Prev. Close
26,597.5
Market Cap.
₹20,92,683.48
Div Yield
0.52
PE
41.69
PB
41.69
26,367.1
26,659.6
Performance
One Week (%)
2.3
One Month (%)
2.82
One Year (%)
20.05
YTD (%)
20.83
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 27,745 | 27,955 | 27,650 | 2,701 |
Cipla Ltd | 1,457.7 | 1,463 | 1,443.5 | 7,82,697 |
Dr Reddys Laboratories Ltd | 1,174.8 | 1,178.4 | 1,157.7 | 15,70,471 |
Lupin Ltd | 2,380.9 | 2,410 | 2,357.5 | 12,51,257 |
Torrent Pharmaceuticals Ltd | 4,990.5 | 5,068.5 | 4,946.5 | 4,36,202 |
Ipca Laboratories Ltd | 1,749.7 | 1,751 | 1,682.5 | 1,78,310 |
Sun Pharmaceutical Industries Ltd | 1,939.4 | 1,968.2 | 1,934 | 17,68,945 |
Aurobindo Pharma Ltd | 1,618.4 | 1,625 | 1,567 | 12,20,279 |
Wockhardt Ltd | 2,040.1 | 2,047 | 1,991.1 | 4,25,594 |
Ajanta Pharma Ltd | 3,444.5 | 3,527.9 | 3,403.1 | 1,08,703 |
Gland Pharma Ltd | 2,536.8 | 2,595.7 | 2,531.1 | 2,68,436 |
Biocon Ltd | 424.95 | 428.65 | 422.3 | 28,53,304 |
Alkem Laboratories Ltd | 5,654.5 | 5,665.5 | 5,556 | 80,658 |
Glenmark Pharmaceuticals Ltd | 2,251.7 | 2,263.3 | 2,202.2 | 3,52,346 |
Zydus Lifesciences Ltd | 1,112.3 | 1,130 | 1,103.8 | 9,21,919 |
Divis Laboratories Ltd | 8,396.5 | 8,441 | 8,333 | 2,69,724 |
Mankind Pharma Ltd | 2,448.8 | 2,461.9 | 2,435.1 | 95,638 |
Laurus Labs Ltd | 1,840.5 | 1,856.6 | 1,834.5 | 18,69,580 |
Sai Life Sciences Ltd | 1,388.5 | 1,394 | 1,355.4 | 2,83,375 |
Piramal Pharma Ltd | 207.16 | 208 | 200.36 | 84,29,608 |
Indian benchmark indices ended sharply higher on August 3, with the Sensex gaining 544 points and the Nifty closing at 24,774. Strong buying in IT stocks, easing crude oil prices, improving FII sentiment, and the rollout of the new Closing Auction Session (CAS) drove the rally, while investors remained focused on the upcoming RBI policy meeting.
3 Aug 2026|05:57 PM
Indian stock markets ended sharply higher on July 29, 2026, with the Sensex gaining 888.68 points and the Nifty closing at 24,250.20. The rally was driven by sustained buying in IT stocks, positive FII inflows, lower market volatility, and expectations of an unchanged US Federal Reserve interest rate. Infosys led the IT surge, while broad-based gains across FMCG, Metals, Pharma, and Financials boosted overall market sentiment.
29 Jul 2026|06:14 PM
Indian stock markets remained flat on Tuesday, but IT stocks surged as investors shifted focus from global AI hardware concerns toward Indian software companies. TCS, Tech Mahindra and HCLTech led the rally.
28 Jul 2026|11:46 AM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
